Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023)

PHASE3CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

October 27, 2005

Primary Completion Date

May 22, 2006

Study Completion Date

May 22, 2006

Conditions
Anesthesia, General
Interventions
DRUG

Sugammadex

At least 15 minutes after the intubation dose or the last maintenance dose of rocuronium, an intravenous single bolus dose of 4.0 mg/kg Org 25969 was administered.

DRUG

Rocuronium

Each participant received an intravenous single bolus dose of 0.6 mg/kg rocuronium. If further neuromuscular block was required after endotracheal intubation, maintenance dose(s) of 0.15 mg/kg rocuronium was/were administered.

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00298831 - Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023) | Biotech Hunter | Biotech Hunter